Premium
The Finnish national guideline for diagnosis, treatment and follow‐up of patients with wet age‐related macular degeneration
Author(s) -
Tuuminen Raimo,
UusitaloJärvinen Hannele,
Aaltonen Vesa,
Hautala Nina,
Kaipiainen Sulevi,
Laitamäki Nina,
Ollila Marko,
Rantanen Jari,
Välimäki Satu,
Sipilä Raija,
Laukkala Tanja,
Komulainen Jorma,
Tommila Petri,
Immonen Ilkka,
Tuulonen Anja,
Kaarniranta Kai
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13501
Subject(s) - macular degeneration , guideline , medicine , context (archaeology) , incidence (geometry) , health care , optometry , degeneration (medical) , intensive care medicine , pediatrics , ophthalmology , pathology , geography , physics , archaeology , economic growth , optics , economics
Age‐related macular degeneration ( AMD ) is the main cause of visual impairment in developed countries. Several improvements in the visualization of posterior segment of the eye together with the introduction of intravitreal anti‐ VEGF treatment have revolutionized the prognosis of the wet form of AMD ( wAMD ). Increasing incidence of wAMD together with the limited resources of society and of the healthcare system poses challenges for the provision and development of care. In context of these current aspects, we aimed to set evidence‐based medical guidelines for diagnosis, treatment and follow‐up of patients with wAMD .